Lista de obras - Lisa H. Butterfield - Dominio Público Uruguay

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

A Phase I/II Trial Testing Immunization of Hepatocellular Carcinoma Patients with Dendritic Cells Pulsed with Four -Fetoprotein Peptides

artículo científico publicado en 2006

A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapies.

artículo científico publicado en 2012

A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602)

artículo científico publicado en 2013

A short course of neoadjuvant IRX-2 induces changes in peripheral blood lymphocyte subsets of patients with head and neck squamous cell carcinoma

artículo científico publicado en 2011

A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers".

artículo científico publicado en 2008

Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients.

artículo científico publicado en 2014

Antigen presentation by MART-1 adenovirus-transduced interleukin-10-polarized human monocyte-derived dendritic cells

artículo científico publicado en 2004

Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem

artículo científico publicado en 2014

Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study.

artículo científico publicado en 2016

Antioxidant function of recombinant human natural killer enhancing factor

artículo científico publicado en 1995

Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas

artículo científico publicado en 2007

B cells and tertiary lymphoid structures promote immunotherapy response

artículo científico publicado en 2020

Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma

artículo científico publicado en 2015

Cancer immunotherapy trials: leading a paradigm shift in drug development

artículo científico publicado en 2016

Cancer immunotherapy using gene-modified dendritic cells.

artículo científico publicado en 2002

Cancer vaccines

artículo científico publicado en 2015

Cellular immunity induced by a recombinant adenovirus- human dendritic cell vaccine for melanoma.

artículo científico publicado en 2013

Cloning and analysis of MART-1/Melan-A human melanoma antigen promoter regions

artículo científico publicado en 1997

Cloning and sequence analysis of candidate human natural killer-enhancing factor genes

artículo científico publicado en 1994

Consensus nomenclature for CD8(+) T cell phenotypes in cancer

artículo científico publicado en 2015

Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop

scientific article published on 04 July 2019

Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee

artículo científico publicado en 2020

Defining the critical hurdles in cancer immunotherapy

artículo científico publicado en 2011

Dendritic Cell-Based Cancer Vaccines

artículo científico publicado en 2018

Dendritic cell control of immune responses

artículo científico publicado en 2015

Dendritic cell-based vaccines positively impact natural killer and regulatory T cells in hepatocellular carcinoma patients.

artículo científico publicado en 2011

Dendritic cells in cancer immunotherapy clinical trials: are we making progress?

artículo científico publicado en 2013

Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?

artículo científico publicado en 2011

Development of a potency assay for human dendritic cells: IL-12p70 production.

artículo científico publicado en 2008

Dysregulated NF-κB-Dependent ICOSL Expression in Human Dendritic Cell Vaccines Impairs T-cell Responses in Patients with Melanoma

artículo científico publicado en 2020

Ectopic T-bet expression licenses dendritic cells for IL-12-independent priming of type 1 T cells in vitro.

artículo científico publicado en 2009

Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology

artículo científico publicado en 2009

Ependymomas: development of immunotherapeutic strategies.

artículo científico publicado en 2013

Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular carcinoma

artículo científico publicado en 2014

Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human alpha-fetoprotein

artículo científico publicado en 2000

From cytoprotection to tumor suppression: the multifactorial role of peroxiredoxins.

artículo científico publicado en 1999

Function but not phenotype of melanoma peptide-specific CD8(+) T cells correlate with survival in a multiepitope peptide vaccine trial (ECOG 1696).

artículo científico publicado en 2012

Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cells

artículo científico publicado en 2000

Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy

artículo científico publicado en 2017

Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumab

artículo científico publicado en 2014

Immune responses and outcome after vaccination with glioma-associated antigen peptides and poly-ICLC in a pilot study for pediatric recurrent low-grade gliomas

artículo científico publicado en 2016

Immuno-oncology biomarkers 2010 and beyond: perspectives from the iSBTc/SITC biomarker task force.

artículo científico publicado en 2010

Immunogenicity and antitumor effects of vaccination with peptide vaccine+/-granulocyte-monocyte colony-stimulating factor and/or IFN-alpha2b in advanced metastatic melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696.

scientific article published on February 2009

Immunologic Monitoring of Cancer Vaccine Trials Using the ELISPOT Assay

artículo científico publicado en 2014

Immunosuppressive effects of interleukin-12 coexpression in melanoma antigen gene-modified dendritic cell vaccines

artículo científico publicado en 2002

Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts

artículo científico publicado en 2018

Immunotherapy biomarkers 2016: overcoming the barriers.

scientific article published on 21 March 2017

Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting.

artículo científico publicado en 2016

Immunotherapy of hepatocellular carcinoma: Unique challenges and clinical opportunities

artículo científico publicado en 2012

Impact of checkpoint blockade on cancer vaccine-activated CD8+ T cell responses

artículo científico publicado en 2020

Improving the therapeutic index in adoptive cell therapy: key factors that impact efficacy

artículo científico publicado en 2020

Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulo

artículo científico publicado en 2010

Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC.

artículo científico publicado en 2014

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

artículo científico publicado en 2020

Intratumoral IL-12 Gene Therapy Results in the Crosspriming of Tc1 Cells Reactive Against Tumor-associated Stromal Antigens ⬇️

artículo científico publicado el 28 de diciembre de 2010

Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial

artículo científico publicado en 2014

Lentivirally engineered dendritic cells activate AFP-specific T cells which inhibit hepatocellular carcinoma growth in vitro and in vivo.

artículo científico publicado en 2011

Lessons learned from cancer vaccine trials and target antigen choice

scientific article published on 03 February 2016

Measurements of natural killer (NK) cells.

artículo científico publicado en 2014

Melanoma antigen-specific effector T cell cytokine secretion patterns in patients treated with ipilimumab

artículo científico publicado en 2017

Melanoma cancer vaccines and anti-tumor T cell responses.

artículo científico publicado en 2007

Melanoma-associated leukoderma - immunology in black and white?

artículo científico publicado en 2013

Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanoma

artículo científico publicado en 2019

Multiplex serum biomarker assessments: technical and biostatistical issues

artículo científico publicado en 2011

Natural killer cells play a critical role in the immune response following immunization with melanoma-antigen-engineered dendritic cells

artículo científico publicado en 2005

Novel technologies and emerging biomarkers for personalized cancer immunotherapy

artículo científico publicado en 2016

Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge 2018" (28-29 November, 2018, Naples, Italy)

scientific article published on 29 November 2019

Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy).

artículo científico publicado en 2018

Phase I dendritic cell p53 peptide vaccine for head and neck cancer

artículo científico publicado en 2014

Phenotypic and functional testing of circulating regulatory T cells in advanced melanoma patients treated with neoadjuvant ipilimumab.

scientific article published on 21 June 2016

Pitfalls in retrospective analyses of biomarkers: a case study with metastatic melanoma patients.

artículo científico publicado en 2011

Preamble to the 2015 SITC immunotherapy biomarkers taskforce

artículo científico publicado en 2015

Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-α but Not Observation in Intermediate Risk Melanoma Patients

artículo científico publicado en 2015

Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer.

artículo científico publicado en 2016

Prospective Clinical Testing of Regulatory Dendritic Cells in Organ Transplantation

artículo científico publicado en 2016

Randomized controlled trial of a collaborative care intervention to manage cancer-related symptoms: lessons learned.

artículo científico publicado en 2011

Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After

artículo científico publicado en 2015

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers

artículo científico publicado en 2011

Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus

artículo científico publicado en 2008

Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma

artículo científico publicado en 2015

SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: online resources and useful tools - a compass in the land of biomarker discovery

artículo científico publicado en 2011

Society for immunotherapy of cancer (SITC) statement on the proposed changes to the common rule

scientific article published on 21 June 2016

Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial

artículo científico publicado en 2022

Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer.

artículo científico publicado en 2007

Spontaneous immune responses against glioma-associated antigens in a long term survivor with malignant glioma.

artículo científico publicado en 2007

Surveillance of the eye and vision in a clinical trial of MART1-transformed dendritic cells for metastatic melanoma

artículo científico publicado en 2004

Systematic evaluation of immune regulation and modulation

artículo científico publicado en 2017

The great debate at "Immunotherapy Bridge 2018", Naples, November 29th, 2018

scientific article published on 15 August 2019

The need for a network to establish and validate predictive biomarkers in cancer immunotherapy

artículo científico publicado en 2017

Three antigen-loading methods in dendritic cell vaccines for metastatic melanoma.

artículo científico publicado en 2018

Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop

artículo científico publicado en 2019

Tumor-Derived α-Fetoprotein Suppresses Fatty Acid Metabolism and Oxidative Phosphorylation in Dendritic Cells

scientific article published on 15 April 2019

Tumor-derived α-fetoprotein impairs the differentiation and T cell stimulatory activity of human dendritic cells

artículo científico publicado en 2014

Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation

artículo científico publicado en 2016

Validation of biomarkers to predict response to immunotherapy in cancer: Volume II - clinical validation and regulatory considerations

artículo científico publicado en 2016

Web-based collaborative care intervention to manage cancer-related symptoms in the palliative care setting.

artículo científico publicado en 2016

Zinc in innate and adaptive tumor immunity.

artículo científico publicado en 2010

α-Fetoprotein and other tumour-associated antigens for immunotherapy of hepatocellular cancer

artículo científico publicado en 2008

Lista de obras de Lisa H. Butterfield

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

A Phase I/II Trial Testing Immunization of Hepatocellular Carcinoma Patients with Dendritic Cells Pulsed with Four -Fetoprotein Peptides

A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapies.

A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602)

A short course of neoadjuvant IRX-2 induces changes in peripheral blood lymphocyte subsets of patients with head and neck squamous cell carcinoma

A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers".

Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients.

Antigen presentation by MART-1 adenovirus-transduced interleukin-10-polarized human monocyte-derived dendritic cells

Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem

Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study.

Antioxidant function of recombinant human natural killer enhancing factor

Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas

B cells and tertiary lymphoid structures promote immunotherapy response

Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma

Cancer immunotherapy trials: leading a paradigm shift in drug development

Cancer immunotherapy using gene-modified dendritic cells.

Cancer vaccines

Cellular immunity induced by a recombinant adenovirus- human dendritic cell vaccine for melanoma.

Cloning and analysis of MART-1/Melan-A human melanoma antigen promoter regions

Cloning and sequence analysis of candidate human natural killer-enhancing factor genes

Consensus nomenclature for CD8(+) T cell phenotypes in cancer

Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop

Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee

Defining the critical hurdles in cancer immunotherapy

Dendritic Cell-Based Cancer Vaccines

Dendritic cell control of immune responses

Dendritic cell-based vaccines positively impact natural killer and regulatory T cells in hepatocellular carcinoma patients.

Dendritic cells in cancer immunotherapy clinical trials: are we making progress?

Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?

Development of a potency assay for human dendritic cells: IL-12p70 production.

Dysregulated NF-κB-Dependent ICOSL Expression in Human Dendritic Cell Vaccines Impairs T-cell Responses in Patients with Melanoma

Ectopic T-bet expression licenses dendritic cells for IL-12-independent priming of type 1 T cells in vitro.

Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology

Ependymomas: development of immunotherapeutic strategies.

Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular carcinoma

Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human alpha-fetoprotein

From cytoprotection to tumor suppression: the multifactorial role of peroxiredoxins.

Function but not phenotype of melanoma peptide-specific CD8(+) T cells correlate with survival in a multiepitope peptide vaccine trial (ECOG 1696).

Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cells

Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy

Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumab

Immune responses and outcome after vaccination with glioma-associated antigen peptides and poly-ICLC in a pilot study for pediatric recurrent low-grade gliomas

Immuno-oncology biomarkers 2010 and beyond: perspectives from the iSBTc/SITC biomarker task force.

Immunogenicity and antitumor effects of vaccination with peptide vaccine+/-granulocyte-monocyte colony-stimulating factor and/or IFN-alpha2b in advanced metastatic melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696.

Immunologic Monitoring of Cancer Vaccine Trials Using the ELISPOT Assay

Immunosuppressive effects of interleukin-12 coexpression in melanoma antigen gene-modified dendritic cell vaccines

Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts

Immunotherapy biomarkers 2016: overcoming the barriers.

Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting.

Immunotherapy of hepatocellular carcinoma: Unique challenges and clinical opportunities

Impact of checkpoint blockade on cancer vaccine-activated CD8+ T cell responses

Improving the therapeutic index in adoptive cell therapy: key factors that impact efficacy

Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulo

Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC.

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

Intratumoral IL-12 Gene Therapy Results in the Crosspriming of Tc1 Cells Reactive Against Tumor-associated Stromal Antigens ⬇️

Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial

Lentivirally engineered dendritic cells activate AFP-specific T cells which inhibit hepatocellular carcinoma growth in vitro and in vivo.

Lessons learned from cancer vaccine trials and target antigen choice

Measurements of natural killer (NK) cells.

Melanoma antigen-specific effector T cell cytokine secretion patterns in patients treated with ipilimumab

Melanoma cancer vaccines and anti-tumor T cell responses.

Melanoma-associated leukoderma - immunology in black and white?

Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanoma

Multiplex serum biomarker assessments: technical and biostatistical issues

Natural killer cells play a critical role in the immune response following immunization with melanoma-antigen-engineered dendritic cells

Novel technologies and emerging biomarkers for personalized cancer immunotherapy

Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge 2018" (28-29 November, 2018, Naples, Italy)

Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy).

Phase I dendritic cell p53 peptide vaccine for head and neck cancer

Phenotypic and functional testing of circulating regulatory T cells in advanced melanoma patients treated with neoadjuvant ipilimumab.

Pitfalls in retrospective analyses of biomarkers: a case study with metastatic melanoma patients.

Preamble to the 2015 SITC immunotherapy biomarkers taskforce

Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-α but Not Observation in Intermediate Risk Melanoma Patients

Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer.

Prospective Clinical Testing of Regulatory Dendritic Cells in Organ Transplantation

Randomized controlled trial of a collaborative care intervention to manage cancer-related symptoms: lessons learned.

Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers